Priority Date: 15.06.12 (US 201261660327P)

ANTI-CD22 ANTI-IDIOTYPIC ANTIBODIES AND USES THEREOF

  • Application ID: EP13804606
  • Status: EXAMINATION IN PROGRESS

Attorney

no operation time available
Headquarter in Munich
active in Legal Services

Specialization

This patent has the IPC combination A61, C07, and C12 Lederer Keller Patentanwälte Partnerschaft mbB is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB, Isenbruck Bösl Hörschler LLP and 128 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.06.2012 - Priority Date (US 201261660327P)
  • 19.12.2013 - Publication A2 (WO2013188864)
  • 22.04.2015 - Publication A2 (EP2861622)

IPC Classification